T-wave alternans in risk stratification of patients with nonischemic dilated cardiomyopathy: Can it help to better select candidates for ICD implantation?

Heart Rhythm

Volumn 6, Issue 3 SUPPL., 2009, Pages

  De Ferrari, Gaetano M ^a   Sanzo, Antonio ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Heart failure; Nonischemic cardiomyopathy; Risk stratification; Sudden death; T wave alternans

Indexed keywords

ANTIARRHYTHMIC AGENT;

ARTICLE; CONGESTIVE CARDIOMYOPATHY; DEFIBRILLATOR; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; NONISCHEMIC DILATED CARDIOMYOPATHY; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RISK REDUCTION; STATISTICAL ANALYSIS; SUDDEN DEATH; T WAVE; T WAVE ALTERNANS;

CARDIOMYOPATHY, DILATED; CONFIDENCE INTERVALS; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK; RISK ASSESSMENT; RISK FACTORS;

EID: 60949105674     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2008.10.008     Document Type: Article

References (32)

1. Zipes D.P., Camm A.J., Borggrefe M., et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death-executive summary: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines
2. Bardy G.H., Lee K.L., Mark D.B., et al., Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
3. Kadish A., Dyer A., Daubert J.P., et al., Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350 (2004) 2151-2158
4. Rosenqvist M., Beyer T., Block M., et al. Adverse events with transvenous implantable cardioverter-defibrillators: a prospective multicenter study. European 7219 Jewel ICD investigators. Circulation 98 (1998) 663-670
5. Schron E.B., Exner D.V., Yao Q., et al. Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 105 (2002) 589-594
6. Vermeulen J.T. Mechanisms of arrhythmias in heart failure. J Cardiovasc Electrophysiol 9 (1998) 208-221
7. Zipes D.P., and Wellens H.J. Sudden cardiac death. Circulation 98 (1998) 2334-2351
8. De Ferrari G.M., and Tavazzi L. The role of arrhythmias in the progression of heart failure. Eur J Heart Fail 1 (1999) 35-40
9. Moss A.J., Zareba W., Hall W.J., et al., Multicenter automatic defibrillator implantation trial II investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
10. Gomes J.A., Winters S.L., and Ip J. Post myocardial infarction stratification and the signal-averaged electrocardiogram. Prog Cardiovasc Dis 35 (1993) 263-270
11. Buxton A.E., Lee K.L., DiCarlo L., et al. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 34 (2000) 1937-1945
12. De Ferrari G.M., Rordorf R., Frattini F., et al. Predictive value of programmed ventricular stimulation in patients with ischaemic cardiomyopathy: implications for the selection of candidates for an implantable defibrillator. Europace 9 (2007) 1151-1157
13. Grimm W., Glaveris C., Hoffmann J., et al. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: design and first results of the Marburg Cardiomyopathy Study. Pacing Clin Electrophysiol 21 (1998) 2551-2556
14. Verrier R.L., and Tolat A. Dynamic repolarization changes and arrhythmia risk assessment in nonischemic heart disease. In: Malik M., and Camm A.J. (Eds). Dynamic Electrocardiography (2004), Blackwell Futura, Oxford, UK 454-462
15. Qian Y.W., Clusin W.T., Lin S.F., et al. Spatial heterogeneity of calcium transient alternans during the early phase of myocardial ischeamia in the blood-perfused rabbit heart. Circulation 104 (2001) 2082-2087
16. Schwartz P.J., and Malliani A. Electrical alternation of the T-wave: clinical and experimental evidence of its relationship with the sympathetic nervous system and with the long Q-T syndrome. Am Heart J 89 (1975) 45-50
17. Kovach J.A., Nearing B.D., and Verrier R.L. Angerlike behavioural state potentiates myocardial ischaemia-induced T-wave alternans in canines. J Am Coll Cardiol 37 (2001) 1719-1725
18. Klingenheben T., Zabel M., D'Agostino R.B., et al. Predictive value of T-wave alternans for arrhythmic events in patients with congestive heart failure. Lancet 356 (2000) 651-652
19. Hennersdorf M.G., Perings C., Niebch V., et al. T wave alternans as a risk predictor in patients with cardiomyopathy and mild-to-moderate heart failure. PACE 23 (2000) 1386-1391
20. Sakabe K., Ikeda T., Sakata T., et al. Comparison of T-wave alternans and QT interval dispersion to predict ventricular tachyarrhythmia in patients with dilated cardiomyopathy and without antiarrhythmic drugs: a prospective study. Jpn Heart J 42 (2001) 451-457
21. Adachi K., Ohnishi Y., and Yokoyama M. Risk stratification for sudden cardiac death in dilated cardiomyopathy using microvolt-level T-wave alternans. Jpn Circ J 65 (2001) 76-80
22. Kitamura H., Ohnishi Y., Okajima K., et al. Onset heart rate of microvolt-level T-wave alternans provides clinical and prognostic value in nonischemic dilated cardiomyopathy. J Am Coll Cardiol 39 (2002) 295-300
23. Hohnloser S.H., Klingenheben T., Bloomfield D., et al. Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: results from a prospective observational study. J Am Coll Cardiol 41 (2003) 2220-2224
24. Grimm W., Christ M., Bach J., et al. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy. Results of the Marburg Cardiomyopathy Study. Circulation 108 (2003) 2883-2891
25. Bloomfield D.M., Bigger J.T., Steinman R.C., et al. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol 47 (2006) 456-463
26. 2 uptake and microvolt level T-wave alternans in patients with idiopathic dilated cardiomyopathy. Int J Cardiol 131 (2007) 23-29
27. Gold R.M., Ensley D., Chilson D., et al. T-Wave Alternans SCD HeFT study: primary endpoint analysis. Circulation 114 Suppl (2006) II_428-II_429 (abstr)
28. Cantillon D.J., Stein K.M., Markowitz S.M., et al. Predictive value of microvolt T-wave alternans in patients with left ventricular dysfunction. J Am Coll Cardiol 50 (2007) 166-173
29. Salerno-Uriarte J.A., De Ferrari G.M., Klersy C., et al., ALPHA Study Group Investigators. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy. J Am Coll Cardiol 50 (2007) 1896-1904
30. Klingenheben T., Ptaszynski P., and Hohnloser S.H. Quantitative assessment of microvolt T-wave alternans in patients with congestive heart failure. J Cardiovasc Electrophysiol 16 (2005) 620-624
31. Verrier R.L., Kwaku K.F., Nearing B.D., et al. T-wave alternans: does size matter?. J Cardiovasc Electrophysiol 16 (2005) 625-627
32. Minkkinen M., Kahonen M., Viik J., et al. Enhanced predictive power of quantitative TWA during routine exercise testing in the Finnish Cardiovascular Study. J Cardiovasc Electrophysiol (2008) In press doi:10.1111/j.1540-8167.2008.01325.x